AMG 747

DRUG2 trials

Sponsors

Amgen

Conditions

Schizophrenia

Phase 2

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

TerminatedNCT01568216

AmgenSchizophrenia

Start: 2012-05-31End: 2013-06-30Updated: 2015-07-30

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)

TerminatedNCT01568229

AmgenSchizophrenia

Start: 2012-05-31End: 2013-08-31Updated: 2014-10-01

Related Papers

Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia.

2016-10-2426 citations